cached image

Stefano Cataldi - Publications

Affiliations: 
2012-2012 Medical Science Università di Ferrara, Ferrara, Emilia-Romagna, Italy 
 2014-2018 Medical Genetics University of British Columbia, Vancouver, Vancouver, BC, Canada 
 2018- Psychiatry Columbia University, New York, NY 
Area:
Parkinson's, Neurochemistry, Microdialysis, Behavior, Neurodegeneration, Neuroscience
Website:
https://www.linkedin.com/in/stefano1cataldi1neuroscience/

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Cataldi S, Lacefield C, N S, Kumar G, Boumhaouad S, Sulzer D. Decreased dorsomedial striatum direct pathway neuronal activity is required for learned motor coordination. Eneuro. PMID 36171055 DOI: 10.1523/ENEURO.0169-22.2022  0.513
2021 Cataldi S, Stanley AT, Miniaci MC, Sulzer D. Interpreting the role of the striatum during multiple phases of motor learning. The Febs Journal. PMID 33977645 DOI: 10.1111/febs.15908  0.476
2020 Somayaji M, Cataldi S, Choi SJ, Edwards RH, Mosharov EV, Sulzer D. A dual role for α-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 33273122 DOI: 10.1073/pnas.2013652117  0.736
2020 Robert J, Weilinger NL, Cao LP, Cataldi S, Button EB, Stukas S, Martin EM, Seibler P, Gilmour M, Caffrey TM, Rowe EM, Fan J, MacVicar B, Farrer MJ, Wellington CL. An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases. Molecular Neurodegeneration. 15: 70. PMID 33213497 DOI: 10.1186/s13024-020-00418-z  0.351
2018 Cataldi S, Follett J, Fox JD, Tatarnikov I, Kadgien C, Gustavsson EK, Khinda J, Milnerwood AJ, Farrer MJ. Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice. Npj Parkinson's Disease. 4: 27. PMID 30155515 DOI: 10.1038/S41531-018-0063-3  0.679
2017 Volta M, Beccano-Kelly DA, Paschall SA, Cataldi S, MacIsaac SE, Kuhlmann N, Kadgien CA, Tatarnikov I, Fox J, Khinda J, Mitchell E, Bergeron S, Melrose H, Farrer MJ, Milnerwood AJ. Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice. Elife. 6. PMID 28930069 DOI: 10.7554/Elife.28377  0.738
2017 Volta M, Beccano-Kelly DA, Paschall SA, Cataldi S, MacIsaac SE, Kuhlmann N, Kadgien CA, Tatarnikov I, Fox J, Khinda J, Mitchell E, Bergeron S, Melrose H, Farrer MJ, Milnerwood AJ. Author response: Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice Elife. DOI: 10.7554/Elife.28377.016  0.776
2016 Cataldi S, Codini M, Hunot S, Légeron FP, Ferri I, Siccu P, Sidoni A, Ambesi-Impiombato FS, Beccari T, Curcio F, Albi E. e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease. Mediators of Inflammation. 2016: 3937057. PMID 27194825 DOI: 10.1155/2016/3937057  0.329
2015 Volta M, Cataldi S, Beccano-Kelly D, Munsie L, Tatarnikov I, Chou P, Bergeron S, Mitchell E, Lim R, Khinda J, Lloret A, Bennett CF, Paradiso C, Morari M, Farrer MJ, et al. Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release. Parkinsonism & Related Disorders. 21: 1156-63. PMID 26282470 DOI: 10.1016/J.Parkreldis.2015.07.025  0.703
2014 Walker MD, Volta M, Cataldi S, Dinelle K, Beccano-Kelly D, Munsie L, Kornelsen R, Mah C, Chou P, Co K, Khinda J, Mroczek M, Bergeron S, Yu K, Cao LP, et al. Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging. Journal of Parkinson's Disease. 4: 483-98. PMID 25000966 DOI: 10.3233/Jpd-140344  0.712
Show low-probability matches.